home / stock / sibn / sibn news

SIBN News and Press, SI-BONE Inc. From 07/23/19

Stock Information
Company Name: SI-BONE Inc.
Stock Symbol: SIBN
Market: NASDAQ
Website: si-bone.com
Menu
SIBN SIBN Quote SIBN Short SIBN News SIBN Articles SIBN Message Board
Get SIBN Alerts

News, Short Squeeze, Breakout and More Instantly...
SIBN - SI-BONE To Report Second Quarter 2019 Financial Results on August 6, 2019

SANTA CLARA, Calif., July 23, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the second quarter of 2019 after market close on...
SIBN - Survey of 1,000 Women Reveals 8 in 10 are Unaware that Sacroiliac Joint Issues are a Leading Cause of Chronic Lower Back Pain After Pregnancy

Findings also show that when left untreated, back pain may lead to weight gain, anxiety and depression Results of a recent survey of 1,000 women (age 35 to 60) conducted by SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal...

SIBN - SI-BONE's iFuse Implant System Surpasses 40,000 Procedures

SANTA CLARA, Calif., June 27, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced today that the iFuse Implant System ® has been used in more than 40,0...

SIBN - SI-BONE (SIBN) Investor Presentation - Slideshow

The following slide deck was published by SI-BONE, Inc. in conjunction with this Read more ...

SIBN - SI-BONE Announces the Addition of Mark Foley and Heyward Donigan to the Board of Directors

­ SANTA CLARA, Calif., June 17, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System®, today announced that Mark J. Foley and Heyward R...

SIBN - SI-BONE to Present at the 2019 JMP Securities Life Sciences Conference

SANTA CLARA, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that management will participate in the upcoming 2019 JMP Securities Life Sciences Co...

SIBN - SI-BONE's (SIBN) CEO Jeff Dunn on Q1 2019 Results - Earnings Call Transcript

SI-BONE, Inc. (SIBN) Q1 2019 Results Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Carrie Mendivil – Gilmartin Group Jeff Dunn – President and Chief Executive Officer Laura Francis – Chief Financial Officer Conference Call Participan...
SIBN - SI-BONE misses by $0.13, misses on revenue

SI-BONE (NASDAQ: SIBN ): Q1 GAAP EPS of -$0.38 misses by $0.13 . More news on: SI-BONE, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

SIBN - SI-BONE, Inc. Reports First Quarter 2019 Financial Results

SANTA CLARA, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended March 31, 2019. Recent Highlights Revenu...

SIBN - SI-BONE to Present at the Bank of America Merrill Lynch 2019 Health Care Conference

­ SANTA CLARA, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that management will participate in the upcoming 2019 Bank of America Merri...
Previous 10 Next 10